Transcript доктором Альдо Скарпо

В рамках программы "Профессорские дни",
организованных совместно с кафедрой
клинической иммунологии МГМСУ им.
А.И.Евдокимова, кафедрой патологии Первого
МГМУ им. И.М.Сеченова, Национальным
исследовательским центром “Курчатовский
институт”, Европейской ассоциацией предиктивнопревентивной и персонифицированной медицины
(EPMA, Brussles, EU) и рядом американских и
европейских университетов, был организован
семинар для учащихся 9-10 классов по
вопросам инструментов доклинической
диагностики и терапевтической
фармакопревенции, основанных на работе с
потенциальными фармакотерапевтическими
мишенями.
Director, Dept for Pathology and Diagnostics
PRESIDENT, Teaching staff council for the Doctorate In Human
Oncological Pathology and Council for the Department of Pathology
Biography
Aldo Scarpa is professor of Pathology and Molecular
Pathology. He is the Director of the Department of Pathology
and Diagnostics and Director of the ARC-NET Research
Centre for Applied Research on Cancer at the University and
Hospital Trust of Verona.
Dr. Scarpa received his MD from the University of Padova,
and his PhD in Molecular Pathology from the University of
Verona. Early in his medical career he served as a family
practitioner and thereafter as deputy director of the Clinical
Pathology Laboratory of the Military Hospital of Verona
before completing his Residency in Pathology at the
University of Parma. His career includes extended periods in
renowned Institutions in Italy Europe, United States of
America, and Japan where has spent one year at the
National Cancer Center of Tokyo.
Dr. Scarpa has been a pioneer since the early ’80s in the
application of molecular biology to the study of cancer. He
founded Molecular Diagnostic Laboratories at Verona
University (1990) and at the Cancer Centre in CuencaEcuador (2001), performing population screening for
cervical cancer using papilloma DNA testing, molecular
diagnosis of leukemias and cancers for therapy decisions
and follow up as well as characterization and monitoring of
bone marrow transplantation. He is a proponent of
biobanking, having begun tissue collections and cancer
modelling in early 80’s. His research interests focus on
cancer pathology and genetics and his work has been
published in over 250 peer-reviewed publications. He is the
Leader of the Italian project within the International Cancer
Genome Consortium